scholarly journals Role of fixed-combination brinzolamide 1%/timolol 0.5% in the treatment of elevated intraocular pressure in open-angle glaucoma and ocular hypertension

2009 ◽  
pp. 593 ◽  
Author(s):  
Henny Beckers
Keyword(s):  
Intraocular Pressure ◽  
Ocular Hypertension ◽  
Fixed Combination ◽  
Open Angle Glaucoma ◽  
Open Angle ◽  
Elevated Intraocular Pressure

scholarly journals What was Glaucoma Called before the 20th Century?

2015 ◽  
Vol 7 ◽  
pp. OED.S32004 ◽  
Author(s):  
Christopher T. Leffler ◽  
Stephen G. Schwartz ◽  
Francesca M. Giliberti ◽  
Matthew T. Young ◽  
Dennis Bermudez
Keyword(s):  
Intraocular Pressure ◽  
Optic Neuropathy ◽  
Primary Open Angle Glaucoma ◽  
Open Angle Glaucoma ◽  
The Other ◽  
Angle Closure ◽  
Open Angle ◽  
Poor Vision ◽  
Elevated Intraocular Pressure

Glaucoma involves a characteristic optic neuropathy, often with elevated intraocular pressure. Before 1850, poor vision with a normal eye appearance, as occurs in primary open-angle glaucoma, was termed amaurosis, gutta serena, or black cataract. Few observers noted palpable hardness of the eye in amaurosis. On the other hand, angle-closure glaucoma can produce a green or gray pupil, and therefore was called, variously, glaucoma (derived from the Greek for glaucous, a nonspecific term connoting blue, green, or light gray) and viriditate oculi. Angle closure, with palpable hardness of the eye, mydriasis, and anterior prominence of the lens, was described in greater detail in the 18th and 19th centuries. The introduction of the ophthalmoscope in 1850 permitted the visualization of the excavated optic neuropathy in eyes with a normal or with a dilated greenish-gray pupil. Physicians developed a better appreciation of the role of intraocular pressure in both conditions, which became subsumed under the rubric “glaucoma”.

scholarly journals Tafluprost for the Reduction of Interocular Pressure in Open Angle Glaucoma and Ocular Hypertension

2011 ◽  
Vol 3 ◽  
pp. OED.S4253 ◽  
Author(s):  
Clyde Schultz
Keyword(s):  
Intraocular Pressure ◽  
Side Effects ◽  
Receptor Antagonist ◽  
Ocular Hypertension ◽  
Clinical Studies ◽  
Open Angle Glaucoma ◽  
Pressure Control ◽  
Open Angle ◽  
Elevated Intraocular Pressure ◽  
Fp Receptor

Tafluprost is an FP receptor antagonist that has been shown in clinical studies in Europe and Japan to be extremely useful in treating elevated intraocular pressure and glaucoma. The drug is well tolerated and appears to be at least equal in effectiveness and perhaps superior to other protanoids for routine use comparison to be superior to other treatments for the elevated IOP as the side effects and other related symptomology appear to be less, while maintaining a level of pressure control for prolonged periods.

Sign in / Sign up

Export Citation Format

Share Document